ONCSQ (OncoSec Medical) Other Stockholders Equity: $-0.00 Mil (As of Jan. 2023)


What is OncoSec Medical Other Stockholders Equity?

OncoSec Medical ONCSQ -99.00% Other Stockholders Equity is $-0.00 Mil as of Jan. 2023.

OncoSec Medical's Other Stockholders Equity for the quarter that ended in Jan. 2023 was $-0.00 Mil.

OncoSec Medical's quarterly Other Stockholders Equity declined from Jul. 2022 ($3.59 Mil) to Oct. 2022 ($3.37 Mil) and declined from Oct. 2022 ($3.37 Mil) to Jan. 2023 ($-0.00 Mil).

OncoSec Medical's annual Other Stockholders Equity declined from Jul. 2020 ($5.71 Mil) to Jul. 2021 ($3.59 Mil) but then increased from Jul. 2021 ($3.59 Mil) to Jul. 2022 ($3.59 Mil).

OncoSec Medical Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for OncoSec Medical's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OncoSec Medical Other Stockholders Equity Chart

OncoSec Medical Annual Data
Trend Jul13 Jul14 Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.27 10.81 5.71 3.59 3.59

OncoSec Medical Quarterly Data
Apr18 Jul18 Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.59 3.59 3.59 3.37 -0.00

OncoSec Medical Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of $-0.00 Mil mean?
OncoSec Medical (ONCSQ) has a Other Stockholders Equity of $-0.00 Mil as of Jan. 2023. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on OncoSec Medical and its competitors.
Is OncoSec Medical's Other Stockholders Equity too high?
OncoSec Medical's current Other Stockholders Equity is $-0.00 Mil.
How does OncoSec Medical's Other Stockholders Equity compare to NOVNQ and USRM?
OncoSec Medical's Other Stockholders Equity of $-0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Biotechnology company?
A good Other Stockholders Equity depends on the Biotechnology industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on OncoSec Medical and its competitors. OncoSec Medical's current Other Stockholders Equity is $-0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OncoSec Medical stock overvalued right now?
OncoSec Medical (ONCSQ) has a current Other Stockholders Equity of $-0.00 Mil. The current Other Stockholders Equity is $-0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For OncoSec Medical (ONCSQ), the current Other Stockholders Equity is $-0.00 Mil as of Jan. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

OncoSec Medical Business Description

Address 820 Bear Tavern Road, Ewing, NJ, USA, 08628-1021
OncoSec Medical Inc is a healthcare sector company. It is focused on designing, developing and commercializing gene therapies, therapeutics, and medical approaches to stimulate an anti-tumor immune response for the treatment of cancer. The company's lead product candidate, ImmunoPulse IL-12, consists of a plasmid construct encoding the proinflammatory cytokine, IL-12, which is delivered into the tumor through in vivo electroporation. In addition, it is pursuing ImmunoPulse IL-12 monotherapy in patients with triple-negative breast cancer.